LON:DEST - Destiny Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 70.50 0.00 (0.00 %)
(As of 12/12/2018 04:00 PM ET)
Previous CloseGBX 70.50
Today's RangeGBX 70.50 - GBX 70.50
52-Week RangeGBX 111 - GBX 235
Average Volume4,205 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Destiny Pharma plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of novel medicines for the treatment of infectious diseases in the United Kingdom. It is involved in developing XF-73 Nasal for the treatment of post-surgical staphylococcal infections; XF-73 Throat for the treatment of staphylococcal hospital/ventilator pneumonia infections; XF-70 Dermal for the treatment of skin burn wound infections of antibiotic resistant bacteria; and XF-70 Lung for the treatment of bacterial biofilm-associated infections. The company has collaboration agreement with China Medical System Holdings Limited. The company was incorporated in 1996 and is headquartered in Brighton, the United Kingdom.

Receive DEST News and Ratings via Email

Sign-up to receive the latest news and ratings for DEST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Biotechnology
Current SymbolLON:DEST
Previous Symbol


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A
Market Cap£0.00

Destiny Pharma (LON:DEST) Frequently Asked Questions

What is Destiny Pharma's stock symbol?

Destiny Pharma trades on the London Stock Exchange (LON) under the ticker symbol "DEST."

How were Destiny Pharma's earnings last quarter?

Destiny Pharma PLC (LON:DEST) posted its quarterly earnings results on Thursday, April, 12th. The company reported ($8.40) earnings per share for the quarter, missing the Zacks' consensus estimate of ($8.30) by $0.10. View Destiny Pharma's Earnings History.

What price target have analysts set for DEST?

0 analysts have issued 1-year target prices for Destiny Pharma's shares. Their forecasts range from GBX 250 to GBX 250. On average, they expect Destiny Pharma's stock price to reach GBX 250 in the next twelve months. This suggests a possible upside of 254.6% from the stock's current price. View Analyst Price Targets for Destiny Pharma.

Has Destiny Pharma been receiving favorable news coverage?

Press coverage about DEST stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Destiny Pharma earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are some of Destiny Pharma's key competitors?

Who are Destiny Pharma's key executives?

Destiny Pharma's management team includes the folowing people:
  • Dr. William Guy Love, Founder, Chief Scientific Officer & Director (Age 55)
  • Mr. Neil Robert Clark, CEO & Director (Age 55)
  • Mr. Simon Emanuel Sacerdoti, CFO, Company Sec. & Director (Age 47)
  • Dr. Jesús M González Moreno, Chief Medical Officer
  • Dr. William Rhys-Williams, Project Director of Microbiology & Pre-Clinical Devel. (Age 50)

How do I buy shares of Destiny Pharma?

Shares of DEST and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Destiny Pharma's stock price today?

One share of DEST stock can currently be purchased for approximately GBX 70.50.

What is Destiny Pharma's official website?

The official website for Destiny Pharma is https://www.destinypharma.com/.

How can I contact Destiny Pharma?

Destiny Pharma's mailing address is Sussex Innovation Centre Science Park Square, Falmer, BRIGHTON, BN1 9SB, United Kingdom. The company can be reached via phone at +44-1273-704440.

MarketBeat Community Rating for Destiny Pharma (LON DEST)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about Destiny Pharma and other stocks. Vote "Outperform" if you believe DEST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DEST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2018 by MarketBeat.com Staff

Featured Article: Moving Average (MA)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel